Table of Contents
Journal of Neurodegenerative Diseases
Volume 2016, Article ID 6163186, 6 pages
http://dx.doi.org/10.1155/2016/6163186
Research Article

Granulovacuolar Degeneration in Hippocampus of Neurodegenerative Diseases: Quantitative Study

1Department of Pathology, London Health Science Centre, Western University, London, ON, Canada N6A 5C1
2Department of Pathology, King Abdul-Aziz University, Jeddah, Saudi Arabia
3Department of Pathology, Schulich School of Medicine & Dentistry, Western University, London, ON, Canada N6A 5C1

Received 11 July 2016; Revised 15 September 2016; Accepted 29 September 2016

Academic Editor: Seishi Terada

Copyright © 2016 Maher Kurdi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Kahn, B. H. Anderton, A. Probst, J. Ulrich, and M. M. Esiri, “Immunohistological study of granulovacuolar degeneration using monoclonal antibodies to neurofilaments,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 48, no. 9, pp. 924–926, 1985. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Hirano, H. M. Dembitzer, L. T. Kurland, and H. M. Zimmerman, “The fine structure of some intraganglionic alterations: neurofibrillary Tangle, Granulovacuolar Bodies and ‘Rod-Like’ structures as seen in guam amyotrophic lateral sclerosis and parkinsonism-dementia complex,” Journal of Neuropathology and Experimental Neurology, vol. 27, no. 2, pp. 167–182, 1968. View at Publisher · View at Google Scholar · View at Scopus
  3. K. E. Funk, R. E. Mrak, and J. Kuret, “Granulovacuolar degeneration (GVD) bodies of Alzheimer's disease (AD) resemble late-stage autophagic organelles,” Neuropathology and Applied Neurobiology, vol. 37, no. 3, pp. 295–306, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Okamoto, S. Hirai, T. Iizuka, T. Yanagisawa, and M. Watanabe, “Reexamination of granulovacuolar degeneration,” Acta Neuropathologica, vol. 82, no. 5, pp. 340–345, 1991. View at Publisher · View at Google Scholar · View at Scopus
  5. R. J. Castellani, Y. Gupta, B. Sheng et al., “A novel origin for granulovacuolar degeneration in aging and Alzheimer's disease: parallels to stress granules,” Laboratory Investigation, vol. 91, no. 12, pp. 1777–1786, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Stadelmann, T. L. Deckwerth, A. Srinivasan et al., “Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease: evidence for apoptotic cell death,” American Journal of Pathology, vol. 155, no. 5, pp. 1459–1466, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Xu, H. Shibayama, H. Kobayashi et al., “Granulovacuolar degeneration in the hippocampal cortex of aging and demented patients—a quantitative study,” Acta Neuropathologica, vol. 85, no. 1, pp. 1–9, 1992. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Is, N. U. Comunoglu, C. Comunoglu, B. Eren, I. D. Ekici, and F. Ozkan, “Age-related changes in the rat hippocampus,” Journal of Clinical Neuroscience, vol. 15, no. 5, pp. 568–574, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. B. E. Tomlinson and D. Kitchener, “Granulovacuolar degeneration of hippocampal pyramidal cells,” Journal of Pathology, vol. 106, no. 3, pp. 165–185, 1972. View at Publisher · View at Google Scholar · View at Scopus
  10. M. J. Ball and P. Lo, “Granulovacuolar degeneration in the ageing brain and in dementia,” Journal of Neuropathology and Experimental Neurology, vol. 36, no. 3, pp. 474–487, 1977. View at Publisher · View at Google Scholar · View at Scopus
  11. J. S. Woodard, “Clinicopathologic significance of granulovacuolar degeneration in Alzheimer's disease,” Journal of Neuropathology and Experimental Neurology, vol. 21, no. 1, pp. 85–91, 1962. View at Publisher · View at Google Scholar · View at Scopus
  12. M. J. Ball, “Topographic distribution of neurofibrillary tangles and granulovacuolar degeneration in hippocampal cortex of aging and demented patients. A quantitative study,” Acta Neuropathologica, vol. 42, no. 2, pp. 73–80, 1978. View at Publisher · View at Google Scholar · View at Scopus
  13. J. C. Steele, J. C. Richardson, and J. Olszewski, “Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia,” Archives of Neurology, vol. 10, no. 4, pp. 333–359, 1964. View at Publisher · View at Google Scholar
  14. M. J. Ball and K. Nuttal, “Topography of neurofibrillary tangles and granulovacuoles in hippocampi of patients with Down's syndrome: Quantitative comparison with normal ageing and Alzheimer's disease,” Neuropathology and Applied Neurobiology, vol. 7, no. 1, pp. 13–20, 1981. View at Publisher · View at Google Scholar
  15. B. E. Tomlinson, G. Blessed, and M. Roth, “Observations on the brains of non-demented old people,” Journal of the Neurological Sciences, vol. 7, no. 2, pp. 331–356, 1968. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Leroy, A. Boutajangout, M. Authelet, J. R. Woodgett, B. H. Anderton, and J.-P. Brion, “The active form of glycogen synthase kinase-3β is associated with granulovacuolar degeneration in neurons in Alzheimers's disease,” Acta Neuropathologica, vol. 103, no. 2, pp. 91–99, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Kadokura, T. Yamazaki, S. Kakuda et al., “Phosphorylation-dependent TDP-43 antibody detects intraneuronal dot-like structures showing morphological characters of granulovacuolar degeneration,” Neuroscience Letters, vol. 463, no. 1, pp. 87–92, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Love, T. Saitoh, S. Quijada, G. M. Cole, and R. D. Terry, “Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, pick bodies and lewy bodies,” Journal of Neuropathology and Experimental Neurology, vol. 47, no. 4, pp. 393–405, 1988. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Yamazaki, T. Takahashi, M. Hiji et al., “Immunopositivity for ESCRT-III subunit CHMP2B in granulovacuolar degeneration of neurons in the Alzheimer's disease hippocampus,” Neuroscience Letters, vol. 477, no. 2, pp. 86–90, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. T. J. Kannanayakal, H. Tao, D. D. Vandre, and J. Kuret, “Casein kinase-1 isoforms differentially associate with neurofibrillary and granulovacuolar degeneration lesions,” Acta Neuropathologica, vol. 111, no. 5, pp. 413–421, 2006. View at Publisher · View at Google Scholar · View at Scopus